ad image

That’s Nice 30

1 / 2
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
First-in-Class Drugs

Breaking New Ground: 30 Years of First-in-Class Drug Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-27Apr 09, 2025
Building Resilient Pharma Supply Chains in an Uncertain World
Supply Chain

Building Resilient Pharma Supply Chains in an Uncertain World

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-26Mar 31, 2025
From Niche to Necessity: How Single-Use Transformed Biomanufacturing
SUT

From Niche to Necessity: How Single-Use Transformed Biomanufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-25Mar 24, 2025
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
RNA

Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-24Mar 21, 2025
Genomics and the Next Era of Precision Medicine
Genomics

Genomics and the Next Era of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-23Mar 20, 2025
Resetting the Biological Clock: OKSM and the Reversal of Aging
Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-22Mar 19, 2025
Clinical Trials Without Borders: The Evolution of Global Drug Development
Global Trials

Clinical Trials Without Borders: The Evolution of Global Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-21Mar 14, 2025
The Final Frontier: Biomanufacturing in Space
Space

The Final Frontier: Biomanufacturing in Space

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-20Mar 13, 2025
From Patients to Partners: The Rising Power of Advocacy in Drug Development
Advocacy

From Patients to Partners: The Rising Power of Advocacy in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-19Mar 13, 2025
Accelerating Patient Access Through Decentralized Clinical Trials
DCTs

Accelerating Patient Access Through Decentralized Clinical Trials

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-18Mar 12, 2025
Global Health at a Crossroads and the Future of Pandemic Preparedness
Pandemic

Global Health at a Crossroads and the Future of Pandemic Preparedness

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-17Mar 12, 2025
The Biomarker Revolution in Medicine and Drug Development
Biomarkers

The Biomarker Revolution in Medicine and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-16Mar 10, 2025
Working Toward a Future Without Neglected Tropical Diseases
NTDs

Working Toward a Future Without Neglected Tropical Diseases

Serene Lee

Nice Insight

PAO-25-30-15Mar 07, 2025
Fighting for Diversity and Equity in Pharma and Biopharma
Diversity

Fighting for Diversity and Equity in Pharma and Biopharma

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-05Mar 06, 2025
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Collaboration

Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-14Mar 03, 2025
The High-Throughput Screening Transformation in Modern Drug Development
HTS

The High-Throughput Screening Transformation in Modern Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-12Mar 02, 2025
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Accelerated Approval

30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-07Mar 02, 2025
The Future is Continuous: Accelerating the Shift in Biomanufacturing
Continuous

The Future is Continuous: Accelerating the Shift in Biomanufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-08Mar 02, 2025
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
Chronic Diseases

Breaking the Cycle of Chronic Disease with New Therapeutic Strategies

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-11Mar 02, 2025
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
Structural Biology

The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-13Mar 02, 2025
1 / 2